Press-release for stocks related to biotech-bay

Prices are updated after-hours

tags : Biotech-bay crawled time : 13:00

save search

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M

Health Technology

| -40.77% | O: 2.19% H: 4.55% C: -10.78%
therapeutics

ASLAN Pharmaceuticals Announces Participation in January Investor Conferences - January 2, 2024
Published: 2024-01-02 (Crawled : 13:00) - biospace.com/
ASLN | News | $0.54 0.0% 26K

Health Technology

| -2.32% | O: -0.4% H: 8.83% C: 5.77%
pharmaceuticals

Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
Published: 2024-01-02 (Crawled : 13:00) - biospace.com/
BTTX | $0.009 -65.02% 180K

| -94.87% | O: 4.1% H: 0.3% C: -10.0%
fda device liver disease treat designation therapeutics platform submission

Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study
Published: 2023-12-18 (Crawled : 13:00) - biospace.com/
GPCR 4 | $36.43 0.69% 0.69% 380K

n/a

| -38.54% | O: -46.08% H: 26.33% C: 6.05%
gsbr-1290 update program therapeutics study

Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
Published: 2023-09-27 (Crawled : 13:00) - biospace.com/
PLSE | $7.2 -2.17% -2.22% 180K

Health Technology

| 72.42% | O: 0.24% H: 4.07% C: -0.96%
association thyroid meeting application technology study

Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943Phase 1 trial enrolling patients with relapsed/refractory AML, MDS and B-cell ALL
Published: 2023-09-14 (Crawled : 13:00) - biospace.com/
VINC | $0.8475 -5.83% -6.19% 350K

| 13.33% | O: 6.93% H: 0.0% C: -0.47%
vip943 pharma trial

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
Published: 2023-09-14 (Crawled : 13:00) - biospace.com/
BSEM | $10.0 -38.71% 39K

n/a

| 351.16% | O: -6.98% H: 0.0% C: 0.0%
NBY | $0.0824 -1.91% 0.0% 1.6M

Health Technology

| -84.01% | O: 7.91% H: 3.52% C: -6.04%
avenova pharmaceuticals commercial

Tenon Medical(R) Announces Expanded Physician Use of New JIB Instrument Kit for Company’s Catamaran(R) SI Joint Fusion System
Published: 2023-09-13 (Crawled : 13:00) - biospace.com/
TNON | $0.7331 -2.25% -2.31% 31K

| -59.69% | O: 10.44% H: 4.0% C: 0.0%
system

Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
Published: 2023-08-15 (Crawled : 13:00) - biospace.com/
BTCY | $1.385 -6.42% -6.86% 100K

Manufacturing

| -44.21% | O: -1.24% H: 5.44% C: 0.42%
business year financial results growth

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
BTCY | $1.385 -6.42% -6.86% 100K

Manufacturing

| -45.34% | O: 0.81% H: 0.0% C: -2.81%
business year update financial results

Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
ANIX | $3.12 0.65% 0.64% 33K

Health Technology

| -16.35% | O: 1.34% H: 1.32% C: -2.12%
presentation cancer car-t therapy

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
ANIX | $3.12 0.65% 0.64% 33K

Health Technology

| -12.11% | O: 2.25% H: 2.2% C: -2.2%
patent vaccine cancer technology

Biotricity Regains Nasdaq Listing Compliance
Published: 2023-07-21 (Crawled : 13:00) - biospace.com/
BTCY | $1.385 -6.42% -6.86% 100K

Manufacturing

| -55.0% | O: 0.33% H: 0.0% C: -1.99%
nasdaq

Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023
Published: 2023-07-19 (Crawled : 13:00) - biospace.com/
CERS | $1.675 2.13% 2.09% 980K

Health Technology

| -39.35% | O: 0.72% H: 5.56% C: 4.66%
corporation financial results

Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
Published: 2023-07-19 (Crawled : 13:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M

Health Technology

| -14.65% | O: -0.15% H: 1.92% C: 1.1%
health pipeline global collaboration hiv impact

Twist Bioscience to Present at Upcoming Investor Conferences - May 24, 2023
Published: 2023-05-24 (Crawled : 13:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 87.33% | O: -2.01% H: 1.03% C: -2.6%
bioscience

RenovoRx to Present at the LD Micro Invitational XIII Conference
Published: 2023-05-24 (Crawled : 13:00) - biospace.com/
RNXT | $1.23 0.82% 0.81% 20K

| -42.08% | O: 2.48% H: 2.9% C: -10.63%
conference

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences - May 24, 2023
Published: 2023-05-24 (Crawled : 13:00) - biospace.com/
ALLO | $3.48 0.58% 0.57% 2M

Health Technology

| -42.64% | O: 1.16% H: 0.0% C: -7.03%
therapeutics

Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
Published: 2023-05-23 (Crawled : 13:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 87.21% | O: 0.27% H: 11.92% C: -0.33%
bioscience